skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Even with the 125M buy back, wouldn't it be a good time to take advantage of the recent drop considering they have 986M of FCF right now? All of the metrics are cheap compared to other banks when looking on Morning Star.

Would it be a good idea to average down my cost or do you think it would drop more?
Read Answer Asked by Benoit on June 01, 2018
Q: the stock was down because the FDA placed a hold on its sickle cell drug until some questions are answered. It was down 20% overnight but now down 9%. Is it time to sell?
Read Answer Asked by hal on June 01, 2018
Q: Peter/Ryan, RESP to be used starting in 3 years has BNS, GUD, OTC & PHO all ~15% + 40% cash. Would COV and/or VB be good additions ~10% each ? What else would you add or subtract ? Thank you.
Read Answer Asked by Paul on June 01, 2018
Q: Good Afternoon,
one month ago I purchased 100 shares of (CHTR) and I am wondering if I made a mistake?? Would you please give me your detailed opinion on this stock. Thank you for your valued reply.
Baldur
Read Answer Asked by Baldur on June 01, 2018
Q: Hello Peter and the team,

Linamar's price has fallen a lot since the earning release. What is the company's outlook next 1-2 years? Is it a good time to buy a partial position? If yes, is it better in TFSA or taxable account?

If you see the same question, please disregard the 1st one. I posted the same question this afternoon, but I couldn't find it.

Thanks.
Read Answer Asked by Iris on June 01, 2018
Q: Hello 5i team,

Today's Globe & Mail:
http://gold.globeinvestor.com/servlet/ArticleNews/story/RTGAM/20180531/ellipsis_OK5KOAGTGVAVZNM33Q4DTLYU4U/stocks/news

Two analysts re-rated Descartes Systems following release of 1st Qtr earning. One analyst (Laurentian Bank), re-rated the stock to "Hold from Buy" on valuation concerns and a slight miss on adjusted earning while all other metrics were higher than analysts' estimates, and then went on and commented on the company's strong potential growth going forward and increased his target to US $32.50. The other analyst (Canaccord), rated the stock a "Buy" and increased his target to US $35.00 from US $34.00. The analyst commented on the company's consistency, M&A activity providing the company's with faster growth segments with expected EBITDA growth of 15% suggesting the stock deserves a premium. Meanwhile the market reacted by selling down the stock with a mid-day drop of CAD $2.00. What gives? Please help me understand what drives markets in the short term and what is your recommendation on Descartes going forward.

Thank you!
Read Answer Asked by Joseph on June 01, 2018
Q: I have held these two stocks for a number of years and I am a great deal under water on both.Would you recommend selling these at this time and move on to GC or DOO or maybe some other stocks you may suggest.
Regards Allen
Read Answer Asked by Allen on June 01, 2018
Q: So now it makes sense why it crashed with no "news" I mean no news for us, but the promoters of the stock, new well in advance of all the inside maneuvers and took their profits , while dumb money are .. well dump money. Pretty much all health care stocks have been a disaster: PHM, CXR, PLI, CRH. The only way to make money on this type of stocks is to be early and leave once everybody is talking about them.
Read Answer Asked by Marios on June 01, 2018
Q: Hi Team,
My question is China Mobile (CHL) and China Mobile HK (CHLKF) are they the same company - one listed in China and one listed in Hong Kong ?
I understand you are not specialize in US ADR, I sure hope you can have an answer for my question.
But if no, I understand !
Thanks as Always ,
Tak
Read Answer Asked by Tak on June 01, 2018
Q: What are your thoughts on BNS at these prices and the negative sentiment around a few things (expense increase, acquisition today SP down 2.5% afterhours, and Russia)? I own the stock but have been looking closely at it lately and wondering if I should be sticking with it, buying more, or moving elsewhere. I feel the south american presence adds diversity but also risk. The market is clearly beating BNS up more than the other banks for a few reasons. Most concerning is when I look at the top 4 biggest banks in size (BNS being 3rd), BNS has performed the worst over 1yr, 2yr, and 5yr periods. Looking at that I'm not seeing the higher dividend being worth the lack of performance. What am I missing?
Read Answer Asked by Adam on June 01, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!